These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8384816)

  • 1. Strategic design and three-dimensional analysis of antiviral drug combinations.
    Prichard MN; Prichard LE; Shipman C
    Antimicrob Agents Chemother; 1993 Mar; 37(3):540-5. PubMed ID: 8384816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of thymidylate synthase and dihydrofolate reductase potentiate the antiviral effect of acyclovir.
    Prichard MN; Prichard LE; Shipman C
    Antiviral Res; 1993 Mar; 20(3):249-59. PubMed ID: 8385896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel thiosemicarbazones derived from formyl- and acyldiazines: synthesis, effects on cell proliferation, and synergism with antiviral agents.
    Easmon J; Heinisch G; Holzer W; Rosenwirth B
    J Med Chem; 1992 Aug; 35(17):3288-96. PubMed ID: 1354751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Acetylpyridine 5-[(dimethylamino)thiocarbonyl]-thiocarbonohydrazone (A1110U), a potent inactivator of ribonucleotide reductases of herpes simplex and varicella-zoster viruses and a potentiator of acyclovir.
    Spector T; Harrington JA; Morrison RW; Lambe CU; Nelson DJ; Averett DR; Biron K; Furman PA
    Proc Natl Acad Sci U S A; 1989 Feb; 86(3):1051-5. PubMed ID: 2536930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of antiherpetic activity of acyclovir by ribonucleotide reductase inhibition.
    Spector T; Averett DR; Nelson DJ; Lambe CU; Morrison RW; St Clair MH; Furman PA
    Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4254-7. PubMed ID: 2987969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of combinations of acyclovir with vidarabine or its 5'-monophosphate on herpes simplex viruses in cell culture and in mice.
    Schinazi RF; Peters J; Williams CC; Chance D; Nahmias AJ
    Antimicrob Agents Chemother; 1982 Sep; 22(3):499-507. PubMed ID: 6182836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibition of herpes simplex virus ribonucleoside diphosphate reductase by derivatives of 2-acetylpyridine thiosemicarbazone.
    Turk SR; Shipman C; Drach JC
    Biochem Pharmacol; 1986 May; 35(9):1539-45. PubMed ID: 3011019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined effects of flavonoids and acyclovir against herpesviruses in cell cultures.
    Mucsi I; Gyulai Z; Béládi I
    Acta Microbiol Hung; 1992; 39(2):137-47. PubMed ID: 1339152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiosemicarbazones of 2-acetylpyridine, 2-acetylquinoline, 1-acetylisoquinoline, and related compounds as inhibitors of herpes simplex virus in vitro and in a cutaneous herpes guinea pig model.
    Shipman C; Smith SH; Drach JC; Klayman DL
    Antiviral Res; 1986 Jul; 6(4):197-222. PubMed ID: 3017201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral activity of 2-acetylpyridine thiosemicarbazones against herpes simplex virus.
    Shipman C; Smith SH; Drach JC; Klayman DL
    Antimicrob Agents Chemother; 1981 Apr; 19(4):682-5. PubMed ID: 6264853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA.
    Chen H; Teng L; Li JN; Park R; Mold DE; Gnabre J; Hwu JR; Tseng WN; Huang RC
    J Med Chem; 1998 Jul; 41(16):3001-7. PubMed ID: 9685239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of herpes simplex virus, vaccinia virus, and adenoviruses to deoxyribonucleic acid inhibitors and thiosemicarbazones in a plaque suppression test.
    Herrmann EC
    Appl Microbiol; 1968 Aug; 16(8):1151-5. PubMed ID: 4300089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acyclovir, cidofovir, and amenamevir have additive antiviral effects on herpes simplex virus TYPE 1.
    Greeley ZW; Giannasca NJ; Porter MJ; Margulies BJ
    Antiviral Res; 2020 Apr; 176():104754. PubMed ID: 32114034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpes simplex virus ribonucleotide reductase mutants are hypersensitive to acyclovir.
    Coen DM; Goldstein DJ; Weller SK
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1395-9. PubMed ID: 2552912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivators of herpes simplex virus ribonucleotide reductase: hematological profiles and in vivo potentiation of the antiviral activity of acyclovir.
    Spector T; Lobe DC; Ellis MN; Blumenkopf TA; Szczech GM
    Antimicrob Agents Chemother; 1992 May; 36(5):934-7. PubMed ID: 1324641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A microtiter virus yield reduction assay for the evaluation of antiviral compounds against human cytomegalovirus and herpes simplex virus.
    Prichard MN; Turk SR; Coleman LA; Engelhardt SL; Shipman C; Drach JC
    J Virol Methods; 1990 Apr; 28(1):101-6. PubMed ID: 2161417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent synergistic inhibition of herpes simplex virus-2 by 9-[(1, 3-dihydroxy-2-propoxy)methyl]guanine in combination with recombinant interferons.
    Eppstein DA; Marsh YV
    Biochem Biophys Res Commun; 1984 Apr; 120(1):66-73. PubMed ID: 6201172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of acyclovir and 9-(1,3-dihydroxy-2-propoxymethyl)guanine on herpes simplex virus and Epstein-Barr virus in a dually infected human lymphoblastoid cell line.
    van der Horst CM; Lin JC; Raab-Traub N; Smith MC; Pagano JS
    J Virol; 1987 Feb; 61(2):607-10. PubMed ID: 3027389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antiviral activity of the ribonucleotide reductase inhibitor BILD 1351 SE in combination with acyclovir against HSV type-1 in cell culture.
    Lawetz C; Liuzzi M
    Antiviral Res; 1998 Jul; 39(1):35-46. PubMed ID: 9754948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Resistance of herpes simplex virus to acyclovir: laboratory and clinical aspects].
    Briazzhikova TS; Iurlova TI; Chizhov NP
    Antibiot Khimioter; 1995; 40(11-12):29-33. PubMed ID: 8830636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.